✦ LIBER ✦

8581 Single centre experience in the use of induction TPF (docetaxel, cisplatin, 5FU) in locally advanced head and neck squamous cell carcinoma (LAHNC)

✍ Scribed by Wai, L. Lip; Mais, K.L.; Sykes, A.J.; Yap, B.; Slevin, N.J.

Book ID: 123597965
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71672-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel induction therapy in locally a

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

✍ Posner, M R; Lefebvre, J L 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Induction chemotherapy with docetaxel, c

Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) followed by radiation and concurrent cetuximab or cisplatin in locally advanced squamous cell carcinoma of the head and neck

✍ Asín Felipe, G.; Arias de La Vega, F.; Errasti Viader, M.; Mañeru, F.; Vera, R.; 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 57 KB

8520 Preliminary results of a pilot stud

8520 Preliminary results of a pilot study with a modified induction docetaxel/cisplatin/5-FU (TPF) followed by concomitant chemoradiotherapy (CT/RT) in locally advanced head and neck cancer (LAHNC)

✍ Serrano, S.; Martinez-Trufero, J.; Miguelsanz, S.; Yubero, A.; Lastra, R.; Polo, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and Response Analysis of TPF (d

Efficacy and Response Analysis of TPF (docetaxel, Cisplatin, 5-fu) Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation Only in Patients with Locally Advanced Squamous Cell Carcinomas of Head and Neck

✍ Mehta, M.J.; Nandwani Patel, P.; Neema, J.; Vyas, R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Phase I trial of concurrent chemoradioth

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Katori, H; Tsukuda, M; Mochimatu, I; Ishitoya, J; Kawai, S; Mikami, Y; Matsuda, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime